RecruitingNCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Sponsor
UMC Utrecht
Enrollment
8,000 participants
Start Date
Feb 1, 2019
Study Type
OBSERVATIONAL
Conditions
Breast CancerLiver CancerEsophageal CancerPancreatic CancerProstate CancerLung CancerHead and Neck CancerQuality of LifeBreast TumorLiver MetastasesRectal CancerEsophagus CancerHead and Neck NeoplasmsGynecologic CancerBladder CancerNeoplasmsTumorOncologyProstate NeoplasmBrain TumorLiver NeoplasmsBrain CancerGynecologic TumorProstate TumorRadiation ToxicityRectal TumorRectal NeoplasmsLung TumorLung NeoplasmEsophageal TumorEsophageal NeoplasmEsophagus TumorEsophagus NeoplasmPancreatic TumorPancreatic NeoplasmsHead and Neck TumorBladder NeoplasmOligometastases
Summary
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
- Patient provides written, informed consent;
- Patient is 18 years old or older.
Exclusion Criteria1
- MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.
Interventions
RADIATIONRadiation therapy
Radiation therapy on the CE marked and FDA approved MR-Linac
Locations(18)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04075305
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location